| Literature DB >> 1720156 |
F De Conno, A Caraceni, E Zecca, E Spoldi, V Ventafridda.
Abstract
We describe the use of hyoscine butylbromide as a subcutaneous infusion in 3 patients with inoperable malignant bowel obstruction. An objective reduction of drainage from the gastrointestinal tract was observed with the hyoscine butylbromide infusion (60-120 mg/day). We suggest that this effect can be useful in the palliative treatment of vomiting in inoperable bowel obstruction.Entities:
Mesh：
Substances：
Year: 1991 PMID： 1720156 DOI： 10.1016/0885-3924(91)90005-o
Source DB: PubMed Journal: J Pain Symptom Manage ISSN： 0885-3924 Impact factor: 3.612